Nippon India Pharma Fund Direct G
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct G
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8259.6
Nippon India Pharma Fund Direct G - Nav Details
Nav Date
: 14-May-2025
NAV [Rs.]
: 549.0539
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct G- NAV Chart
Nippon India Pharma Fund Direct G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 0.25 | 4.9 | 6.5 | -0.38 | 16.21 | 23.66 | 23.55 | 18.13 |
| Category Avg | 0.14 | 3.96 | 1.88 | -2.11 | 18.14 | 23.7 | 23 | 17.13 |
| Category Best | 3.1 | 9.66 | 4.62 | 1.86 | 28.81 | 28.98 | 26.79 | 35.44 |
| Category Worst | -2.06 | 0.8 | -4.11 | -10.47 | 11.89 | 18.95 | 17.49 | -8.24 |
Nippon India Pharma Fund Direct G- Latest Dividends
No Records Found
Nippon India Pharma Fund Direct G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
Akums Drugs3,13,305
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 13.88 | 6256349 | 1,146.35 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.57 | 1298808 | 790.58 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.30 | 2483991 | 520.54 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.01 | 3200000 | 496.03 |
| Equity | Apollo Hospitals | Healthcare Services | 5.48 | 648795 | 452.66 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.25 | 3662170 | 433.56 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 3.63 | 1011921 | 299.99 |
| Equity | Medplus Health | Retailing | 3.54 | 3627277 | 292.41 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.43 | 2831564 | 283.29 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.23 | 88883 | 266.51 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.14 | 959323 | 259.60 |
| Equity | Narayana Hrudaya | Healthcare Services | 3.04 | 1426170 | 251.07 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.59 | 1529352 | 214.10 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.53 | 1702630 | 209.27 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.38 | 709112 | 196.36 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.15 | 2000632 | 177.70 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 2.02 | 503364 | 167.21 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.00 | 323678 | 165.59 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.95 | 999649 | 161.18 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 1.94 | 649036 | 160.00 |
| Equity | Thyrocare Tech. | Healthcare Services | 1.88 | 1765838 | 155.05 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.66 | 230272 | 136.85 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.65 | 318249 | 136.61 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.33 | 785412 | 110.05 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.28 | 213659 | 105.54 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 1.21 | 1430423 | 99.67 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.15 | 3169618 | 94.83 |
| Equity | Fortis Health. | Healthcare Services | 0.92 | 1103889 | 75.67 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 0.89 | 2284222 | 73.50 |
| Equity | Syngene Intl. | Healthcare Services | 0.86 | 1124795 | 71.31 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.67 | 64078 | 55.62 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.52 | 1834924 | 42.67 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.48 | 492727 | 39.46 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 0.37 | 301841 | 30.84 |
| Equity | Krishna Institu. | Healthcare Services | 0.37 | 461785 | 30.33 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.21 | 111738 | 16.96 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.20 | 313305 | 16.36 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 0.36 | 0 | 29.77 |
| Cash & Cash Equivalent | C C I | -/- | 0.00 | 0 | 0.18 |
| Net CA & Others | Net CA & Others | -/- | -0.07 | 0 | -5.85 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
5,61,387.15
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
